Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma
1996

Hepatitis B and C Viruses as Risk Factors for Liver Cancer

Sample size: 361 publication Evidence: high

Author Information

Author(s): JF Tsai, JE Jeng, MS Ho, WY Chang, MY Hsieh, ZY Lin, JH Tsai

Primary Institution: Kaohsiung Medical College, Taiwan

Hypothesis

The study aims to assess the role of hepatitis B e antigen (HBeAg) and its interaction with hepatitis B surface antigen (HBsAg) on the development of hepatocellular carcinoma (HCC).

Conclusion

HBsAg, HBeAg, and anti-HCV are independent risk factors for HCC, with an additive effect between HBsAg and HBeAg.

Supporting Evidence

  • The prevalence of HBeAg, HBsAg, and anti-HCV in HCC patients was significantly higher than in healthy controls.
  • Multivariate analysis indicated that both HBsAg and HBeAg are independent risk factors for HCC.
  • Patients with both HBsAg and HBeAg had the highest odds ratio for developing HCC.

Takeaway

This study found that people with certain hepatitis infections are more likely to develop liver cancer, especially if they have both types of hepatitis B markers.

Methodology

A case-control study comparing 361 patients with HCC to 361 healthy controls matched by age and sex.

Limitations

The study is retrospective, which may affect the reliability of the findings.

Participant Demographics

The study included 303 men and 58 women with a mean age of 53 years.

Statistical Information

P-Value

p<0.0001

Confidence Interval

95% CI, 2.4-27.1 for HBeAg; 95% CI, 20.5-227.8 for HBsAg; 95% CI, 13.6-258.4 for anti-HCV

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication